跳至主要内容
临床试验/JPRN-jRCT1041190125
JPRN-jRCT1041190125招募中未知

Patient REported, Clinical, and Imaging OUtcomes of tapering methotrexate in patients with rheumatoid arthritis in Stable low disease activity with Baricitinib - PRECIOUS-B study

Asai Shuji0 个研究点目标入组 51 人开始时间: 2020年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients fulfilled the 1987 ACR classification criteria or the new ACR/EULAR diagnostic criteria for RA
  • 2) RA patients with sustained low disease activity (CDAI <=10) for >=12 weeks while undergoing combination therapy with BAR plus MTX
  • 3) RA patients receiving BAR, MTX, csDMARDs, and glucocorticoids at a stable dosage regimen for >=12 weeks prior to obtaining informed consent
  • 4) RA patients aged >=20 years
  • 5) Obtaining written informed consent

排除标准

  • 1) Patients with adherence problems
  • 2) Patients judged as inadequate at the discretion of inevstigators

研究者

发起方
Asai Shuji

相似试验

PRECIOUS-B study | 临床试验